An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer

ABSTRACT: The purpose of this study is to predict response to Erbitux as a single agent in patients with metastatic colon cancer

DISEASE(S): Metastatic Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2020036 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR